期刊文献+

原发性肝癌组织中明胶酶A基因表达增强 被引量:4

Gelatinase A gene expression is enhanced in primary hepatocellular carcinoma
原文传递
导出
摘要 目的 了解基质降解对原发性肝癌的作用。方法  33例原发性肝细胞癌患者术中取癌组织及癌旁组织 ;提取组织总RNA ;用逆转录共扩增定量PCR方法测定明胶酶A (MMP2 )基因表达水平。结果 肝癌组织明胶酶A基因表达水平 (3 2 0± 0 34 )明显高于癌旁的肝硬化组织 (0 70±0 16 )及正常肝组织 (0 34± 0 0 7)。肝癌患者MMP2 基因表达水平与血清AFP浓度、肿瘤大小无关。结论 明胶酶A在原发性肝癌的进展中可能起重要作用。 Objective To investigate the role of extracellular matrix degradation on primary hepatocellular carcinoma. MethodsCancerous and paracancerous tissue were obtained from 33 patients with primary hepatocellular carcinoma undergoing surgery. Total RNA was isolated and gelatinase A (MMP 2) gene expression level were rneasured by reverse transcription polymerase chain reaction (RT PCR).Results[WT5”BZ] The gelatinase A (MMP 2) gene expression level in cancerous tissue(3 20±0 34) was much higher than those of cirrhotic tissue(0 70±0 16) and normal liver tissue(0 34±0 07). MMP 2 gene expression levels has no correlation with serum concentration of AFP and tumor size. Conclusion Gelatinase A may play an important role in the progression of primary hepatocellular carcinoma.
出处 《中华普通外科杂志》 CSCD 2000年第10期598-599,共2页 Chinese Journal of General Surgery
关键词 肝细胞癌 明胶酶A 基因表达 基质降解 Carcinoma, hepatocellular Gelatinases Gene expression
  • 相关文献

参考文献5

  • 1Noonan K E,Beck C,Holzmayer T A,et al.Quantitative analysis of MDR1(multidrug resistance) gene expression in human tumors by polymerase chain reaction[].Proceedings of the National Academy of Sciences of the United States of America.1990 被引量:1
  • 2Lichtinghagen R,Helmbrecht T,Arndt B,et al.Expression pattern of matrix metalloproteinases in human liver[].European Journal of Clinical Chemistry.1995 被引量:1
  • 3Nabeshima K,Lane W S,Biswas C.Partial sequencing and Characterization of the tumor cell -derived collagenase stimulatory factor[].Archive of Biochemistry and Biophysics.1991 被引量:1
  • 4Poulsom R,Hanby AM,Pignatelli M,et al.Expression of gelatinase A and TIMP2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin[].Journal of Clinical Pathology.1993 被引量:1
  • 5Emond HP,Remacle AG,Noeel AC,et al.Tumor cell surface associated binding site for the Mr 72 000 type Ⅳ collagenase[].Cancer Research.1992 被引量:1

同被引文献17

  • 1牛旗,汤钊猷,马曾辰,钦伦秀,鲍卫华,张连海.血清基质金属蛋白酶-2与肝细胞癌根治性切除术后转移复发的关系[J].中华肝脏病杂志,2001,9(S1):58-60. 被引量:14
  • 2张明满,李德华,苟兴华,严律南,韩蕾,赵兰英,胡海洋.携反义二型基质金属蛋白酶基因的重组腺病毒的构建[J].中国普外基础与临床杂志,2004,11(5):428-432. 被引量:5
  • 3Samantaray S, Sharma R, Chattopadhyaya TK, et al . Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. J Cancer Res Clin 0ncol,2004,130:37-44. 被引量:1
  • 4Noonan KE, Beck C, Holzmayer TA, et al. Quantitative analysis of MDR1 (muhidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Nail Acad Sci U S A, 1990, 87:7160-7164. 被引量:1
  • 5Ishikawa H,Nakao K,Matsumoto K,et al.Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.Hepatology,2003;37(3):696-704. 被引量:1
  • 6Duffy MJ,McCarthy K.Matrix metalloproteinases in cancer:prognostic markers and targets for therapy (review).Int J Oncol,1998;12(6):1343-1348. 被引量:1
  • 7Vihinen P,Kahari VM.Matrix metalloproteinases in cancer:prognostic markers and therapeutic targets.Int J Cancer,2002;99(2):157-166. 被引量:1
  • 8Egeblad M,Werb Z.New functions for the matrix metalloproteinases in cancer progression.Nat Rev Cancer,2002;2(3):161-174. 被引量:1
  • 9Fridman R,Toth M,Pena D,et al.Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).Cancer Res,1995;55:2548-2555. 被引量:1
  • 10Folgueras AR,Pendas AM,Sanchez LM,Lopez-Otin C.Matrix metalloproteinases in cancer:from new functions to improved inhibition strategies.Int J Dev Biol,2004;48(5-6):411-424. 被引量:1

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部